Eton Pharmaceuticals (ETON) Current Assets (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Current Assets data on file, last reported at $60.6 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 47.68% year-over-year to $60.6 million; the trailing twelve-month figure through Dec 2025 stood at $60.6 million (up 47.68% YoY), and the FY2025 full-year result was $60.6 million, up 47.68% from the prior year.
• Current Assets eased to $60.6 million in Q4 2025, from $72.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $72.0 million in Q3 2025 to a low of $16.4 million in Q3 2022.
• A 5-year average of $32.7 million and a median of $26.6 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 38.06% in 2022 and soared 169.1% in 2025, its largest moves.
• Tracing ETON's Current Assets over 5 years: stood at $23.6 million in 2021, then dropped by 15.25% to $20.0 million in 2022, then soared by 34.17% to $26.8 million in 2023, then soared by 52.84% to $41.0 million in 2024, then surged by 47.68% to $60.6 million in 2025.
• Business Quant data shows ETON's Current Assets at $60.6 million in Q4 2025, $72.0 million in Q3 2025, and $68.4 million in Q2 2025.